Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

In conclusion, Empa therapy protected heart and kidney against CRS injury.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research